Ayvakit Approved to Treat GIST With PDGFRA Exon 18 Mutation

FRIDAY, Jan. 10, 2020 — The kinase inhibitor Ayvakit (avapritinib) has been approved to treat adults with unresectable or metastatic gastrointestinal stromal tumors (GISTs) with a platelet-derived growth factor receptor alpha (PDGFRA) exon 18…
Source: Topamax